Elon Musk’s Terafab chip project is suddenly real, and it has dragged one US stock back into focus. Months ago Musk tied the giant plant to Intel (INTC) and its most advanced technology, and now that Terafab is funded, that endorsement matters again.

Intel stock still slipped about 4% on August 10 to near $97, tracking a fresh share sale, not the Terafab news. No binding deal exists, and Wall Street’s biggest banks cannot agree on what Elon Musk’s interest is worth.

What Elon Musk Said About Intel and Terafab

Terafab is Elon Musk’s plan to build one of Earth’s largest chip factories, the plant he calls the world’s most valuable building. He first named Intel’s 14A process on Tesla’s first-quarter call in April, its next-generation recipe for the smallest, fastest transistors. That would make Terafab the first major customer for 14A, a process Intel has not even finished building.

Then it went quiet. By the next quarter, Musk’s chip spotlight had swung to NVIDIA’s newest processor, and Intel slipped from the story. It roared back this month, once SpaceX and Tesla funded Terafab.

Want more insights like this? Sign up for Editor Harsh Notariya’s Daily Newsletter here.

Intel had joined Elon Musk’s Terafab group in April, and the warmth runs both ways. Intel posted that it was “proud to join” the project alongside SpaceX, xAI, and Tesla, and CEO Lip-Bu Tan praised Musk’s “proven track record of reimagining entire industries.”

Musk’s word carries weight, too. His record personal fortune was built on bets exactly like this, so naming Intel is no idle comment.

The money is serious. In August, SpaceX and Tesla committed $16.8 billion to build the Texas plant.

The catch is the contract. SpaceX’s filing warns that the Terafab partners, Intel among them, are not obligated to stay and that definitive agreements may never be signed. So Musk’s 14A endorsement is a framework, not a booked Intel order.

That gap is why the endorsement matters more as validation than as revenue.

Why It Means Validation, Not Revenue Yet

Intel has told regulators it may pause or discontinue 14A without a major outside customer. A name like Elon Musk is exactly the vote of confidence it needs.

But it is not near-term money. The 14A process reaches high-volume manufacturing in 2028, the point of full commercial scale. External foundry revenue was just $293 million last quarter, against a $2.1 billion foundry loss.

Wall Street is just as split. On July 28, the two biggest banks landed on opposite calls the same day, JPMorgan a sell at $85 and Bank of America a buy at $160. No major analyst has moved a rating since, even as Terafab won its funding (August 6) and Intel launched a $15 billion share sale, the sale of new stock that dilutes existing holders and drove the August 10 dip.

The wider business is healthier. Q2 revenue rose 25% to $16.1 billion. Investors are still pricing a broad turnaround, including bets like Trump’s Intel stake, not a Terafab order book.

That optimism is already priced in. Intel has soared this year despite a recent pullback.

Intel Stock Price Levels to Watch

The chart is where the bull case lives. Since mid-July, Intel has traced an inverse head-and-shoulders, a bullish reversal shape, a dip, a deeper dip, then a shallower dip, that hints sellers are losing their grip. However, the seller-side volume seems to be rising near the right shoulder.

But the conviction behind it looks thin. Since Intel’s July 23 earnings, options traders have leaned bearish, buying more puts, bets the stock falls, and fewer calls, bets it rises. The put/call volume ratio has climbed to 0.79 and open interest to 1.01, a less bullish tilt just as the pattern needs buyers.

The left shoulder of the bullish pattern sits near $89, the head near $81, the right shoulder near $96, under a neckline around $104.

The price action is the tie-breaker. A close above the $104 neckline, roughly 7% away, confirms the breakout and opens $109, $113, and $118, near the average analyst target near $119. A confirmed move points to $126 and then $132. Below $96, the $89 left shoulder is first support, the $81 head the last line.

So Elon Musk’s Terafab hands Intel stock a real option on 14A validation, bullish in shape but short on conviction. It becomes a breakout only above $104 on rising volume (which isn’t there now), and a bankable Terafab story only when a paid deal appears.

Source: BeInCrypto